The global cardiometabolic drugs market is projected to grow from US$ 50 billion in 2021 to over US$ 70 billion by 2032, with a CAGR of 4% to 5%. Sales are expected to surpass US$ 55 billion by 2022, ...
Consumer spending rose fast enough in November to suggest a pretty good start to the holiday shopping season, but not enough to suggest an acceleration in U.S. economic growth.